Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Parenterals, Particulates, and Quality by Design

November 02, 2014

The parenteral manufacturing industry is taking action to address particulate contamination issues.

Continuous Solid-Dosage Manufacturing Platform Nears Prototype Installation

November 02, 2014

A G-CON, GEA, and Pfizer collaboration developed a PCMM (portable, continuous, miniature, and modular) system to produce oral solid-dosage drugs.

Considerations in Developing Sublingual Tablets—An Overview

November 02, 2014

This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets.

PTSM: Pharmaceutical Technology Sourcing and Management

WHO Promotes International Collaboration for Generic Drug Approvals

November 01, 2014

The European Union takes the lead in a global pilot project on the marketing approval of generic medicines, highlighting the challenges of achieving consensus among different nations.

First Biosimilar Application Kicks Off Legal Battle

October 31, 2014

Amgen is suing Sandoz over Sandoz's biosimilar application for filgrastim.

SAFC Introduces New Protein Quality Supplement for Optimized Biologics Production

October 30, 2014

Sigma-Aldrich's custom manufacturing services business unit, SAFC, has launched a new protein quality supplement for biological drug production, including biosimilars.

Seven Steps to Solving Tabletting and Tooling Problems—Step 1: Clean

October 30, 2014

Many factors can contribute to tablet manufacturing problems. Tablet tooling failures are generally the result of one, or a combination of issues.

Novartis Sells Influenza Vaccine Business to CSL for $275 Million

October 27, 2014

The divestment will create the number two player in the global influenza vaccine industry.

GSK Accelerates Ebola Vaccine Development

October 24, 2014

GSK's investigational Ebola vaccine is in Phase I safety trials.

J&J Speeds Ebola Vaccine Development and Expands Production

October 24, 2014

Johnson& Johnson is collaborating with WHO and others on clinical testing, development, production, and distribution of an Ebola vaccine.